Dark

Check out our Level2View

VBIO
Valion Bio, Inc. Common Stock
stock NASDAQ

At Close

Jun 11, 2026 3:50:27 PM EDT

0.6100USD-21.808%(-0.1700)6,910,112

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Jun 11, 2026 9:29:30 AM EDT

0.6270USD-19.615%(-0.1530)1,412,529

After-hours

Jun 11, 2026 4:51:30 PM EDT

0.6019USD-1.312%(-0.0080)19,501

OverviewHistoricalExchangesShortsNews

Sep 2, 2021

11:46PM EDT Vitality Biopharma Announces Effective S-1 Registration Statement GlobeNewswire Inc

Aug 20, 2021

09:00AM EDT Vitality Biopharma, Inc. (VBIO) (Vitality or the Company), an innovation-driven drug development company dedicated to unlocking the therapeutic powers of cannabinoids, today announced that the Company had entered into a definitive agreement with an institutional investor for a $5,000,000 equity line financing. GlobeNewswire Inc

Aug 10, 2021

09:00AM EDT Vitality Biopharma, Inc. (OTC: VBIO) (Vitality or the Company), an innovation-driven drug development company dedicated to unlocking the therapeutic powers of cannabinoids, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to its glycosylated cannabinoid prodrug VBX-100 for the treatment of pediatric ulcerative colitis. GlobeNewswire Inc

Sep 25, 2020

09:00AM EDT Vitality Biopharma Retains DelMorgan & Co. to Explore Strategic GlobeNewswire Inc

Sep 1, 2020

06:03PM EDT Cannabis Stock Gainers And Losers From September 1, 2020 Benzinga

Share